Abstract
Melanoma patients treated with anti-CTLA-4 have shown a range of anti-tumor responses. In this report, we describe the response of a single patient to anti-CTLA-4, with individual lesions disappearing, others stabilizing, and others progressing. These responses can be viewed as a clear manifestation of cancer immunoediting and its three phases of elimination, equilibrium and escape, with each tumor in this patient being at a discrete stage in the process. The patient's course and associated immunological monitoring and other laboratory data are presented in an immunogram, a way to visualize temporal associations between the multiple clinical and laboratory parameters.
Original language | English |
---|---|
Journal | Cancer Immunity |
Volume | 10 |
State | Published - 7 Jan 2010 |
Externally published | Yes |
Keywords
- Case report
- Human
- Immunoediting
- Immunogram
- Ipilimumab
- Melanoma